These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9035)

  • 1. Electrophysiologically determined quinidine-like actions of a beta-adrenergic blocking agent, 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2).
    Tatsuno H; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1976 Jun; 221(2):197-207. PubMed ID: 9035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effects of beta receptor blocking agent, 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2) on the circulatory system during intubation for general anesthesia].
    Kim SY; Miyamoto K; Yoshikawa K
    Masui; 1975 Aug; 24(8):780-6. PubMed ID: 240954
    [No Abstract]   [Full Text] [Related]  

  • 3. Proceedings: Beta-adrenergic blocking and antiarrhythmic activities of 1-(7-indenyloxy)-3-tert-butylaminopropane-2-OL hydrochloride (YB-11).
    Noguchi Y; Nakao K; Kato H; Takagi K
    Jpn J Pharmacol; 1974; 24(0):s:73. PubMed ID: 4151686
    [No Abstract]   [Full Text] [Related]  

  • 4. Direct and beta adrenergic blocking actions of nadolol (SQ 11725) on electrophysiologic properties of isolated canine myocardium.
    Gibson JK; Gelband H; Bassett AL
    J Pharmacol Exp Ther; 1977 Sep; 202(3):702-10. PubMed ID: 19621
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiovascular beta-adrenergic receptor blocking activities of 1-(7-indenyloxy)-3-isopropyl-aminopropane-2-ol hydrochloride (YB-2) and its optical isomers.
    Kato H; Noguchi Y; Nakao K; Takagi K
    Jpn J Pharmacol; 1974 Apr; 24(2):261-70. PubMed ID: 4152803
    [No Abstract]   [Full Text] [Related]  

  • 6. Pharmacological studies on 1-(7-indenyloxy)-3-isopropylaminopropan-2-Ol hydrochloride (YB-2), a new -adrenergic blocking agent.
    Tachikawa S; Takenaka T
    Arch Int Pharmacodyn Ther; 1973 Mar; 202(1):79-92. PubMed ID: 4144371
    [No Abstract]   [Full Text] [Related]  

  • 7. [Membrane stabilizing actions of befunolol and indenolol, new beta-adrenergic receptor blocking drugs (author's transl)].
    Sada H; Harada S; Kojima M; Ban T
    Kokyu To Junkan; 1981 Nov; 29(11):1231-7. PubMed ID: 6121358
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-adrenoceptor blocking and electrophysiological effects of bufetolol in the guinea pig atria.
    Inui J; Imamura H
    Eur J Pharmacol; 1977 Feb; 41(3):251-60. PubMed ID: 14011
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of antiarrhythmic drugs in the isolated papillary muscle preparation of the guinea-pig.
    Bandolet J; Rump S
    Pol J Pharmacol Pharm; 1989; 41(6):519-25. PubMed ID: 2485901
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assessment of beta-blockade and the non-specific effect of bucumolol, a beta-adrenergic blocking agent, on atrioventricular conduction in anesthetized dogs.
    Nakayama K; Oshima T; Koike H
    Arch Int Pharmacodyn Ther; 1981 Nov; 254(1):145-56. PubMed ID: 6121536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The influence on heart conduction time and refractory period of in vitro and in vivo prostaglandins].
    Bayer BL; Förster W; Sperling J
    Arch Int Pharmacodyn Ther; 1976 Jun; 221(2):328-8. PubMed ID: 962440
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Electrophysiological characteristics of tobanum, a new beta receptor blocking agent.
    Solti F; Czakó E
    Int J Clin Pharmacol Ther Toxicol; 1980; 18(5):229-32. PubMed ID: 6104635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-response effects of quinidine on electrophysiological properties of the heart.
    Duncan RJ; Nash CB
    Arch Int Pharmacodyn Ther; 1972 Oct; 199(2):358-67. PubMed ID: 5070647
    [No Abstract]   [Full Text] [Related]  

  • 14. Relative electrophysiological potencies of quinidine, 3-OH quinidine and quinidine-N-oxide in guinea-pig heart.
    Uematsu T; Sato R; Vozeh S; Follath F; Nakashima M
    Arch Int Pharmacodyn Ther; 1989; 297():29-38. PubMed ID: 2730239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison between the tissue uptake of quinidine and its influence on the refractory period in isolated heart muscle.
    Lameijer W; van Zwieten PA
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):321-32. PubMed ID: 4441197
    [No Abstract]   [Full Text] [Related]  

  • 16. Effects of ICI 118.551, a selective beta-2 adrenergic blocking agent on the guinea pig cardiac excitability and ventricular fibrillation threshold.
    Cuparencu B; Tomus C; Gozariu M; Cuprian A
    Acta Physiol Hung; 2000; 87(1):113-26. PubMed ID: 11032054
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiarrhythmic activity of 1-(7-indenyloxy)-3-isopropylaminopropane-2-ol hydrochloride (YB-2) and its optical isomers.
    Kato H; Noguchi Y; Takagi K
    Jpn J Pharmacol; 1974 Aug; 24(4):589-9. PubMed ID: 4455968
    [No Abstract]   [Full Text] [Related]  

  • 18. Electrophysiological effects of aprindine on isolated heart preparations.
    Verdonck F; Vereecke J; Vleugels A
    Eur J Pharmacol; 1974 May; 26(2):338-47. PubMed ID: 4851826
    [No Abstract]   [Full Text] [Related]  

  • 19. The effects of ketamine on conduction velocity and maximum rate of rise of action potential upstroke in guinea pig papillary muscles: comparison with quinidine.
    Hara Y; Tamagawa M; Nakaya H
    Anesth Analg; 1994 Oct; 79(4):687-93. PubMed ID: 7943776
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of dispersion of repolarization and prolongation of postrepolarization refractoriness explain the antiarrhythmic effects of quinidine in a model of short QT syndrome.
    Milberg P; Tegelkamp R; Osada N; Schimpf R; Wolpert C; Breithardt G; Borggrefe M; Eckardt L
    J Cardiovasc Electrophysiol; 2007 Jun; 18(6):658-64. PubMed ID: 17521304
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.